Federation Des Caisses Desjardins Du Quebec Oric Pharmaceuticals, Inc. Transaction History
Federation Des Caisses Desjardins Du Quebec
- $23.7 Billion
- Q3 2025
A detailed history of Federation Des Caisses Desjardins Du Quebec transactions in Oric Pharmaceuticals, Inc. stock. As of the latest transaction made, Federation Des Caisses Desjardins Du Quebec holds 2,000 shares of ORIC stock, worth $26,180. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,000
Previous 2,000
-0.0%
Holding current value
$26,180
Previous $20,000
15.0%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding ORIC
# of Institutions
158Shares Held
105MCall Options Held
35.1KPut Options Held
173K-
Nextech Invest, Ltd. Zurich, V87.16MShares$93.8 Million13.08% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA6.73MShares$88.1 Million6.03% of portfolio
-
Vr Adviser, LLC New York, NY6.6MShares$86.4 Million11.96% of portfolio
-
Viking Global Investors LP6.57MShares$86 Million0.22% of portfolio
-
Nextech Invest Ag5.29MShares$69.2 Million7.95% of portfolio
About Oric Pharmaceuticals, Inc.
- Ticker ORIC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 39,576,700
- Market Cap $518M
- Description
- ORIC Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for treatment of cancers in the United States. Its clinical stage product candidates include ORIC-533, an orally bioavailable small molecule inhibitor of CD73 being developed for resistance to chemotherapy- and immunotherapy-based treatment r...